AtriCure, Inc. (ATRC)
55.14
+1.55
(+2.89%)
USD |
NASDAQ |
Oct 02, 16:00
55.13
-0.01
(-0.02%)
Pre-Market: 20:00
AtriCure Gross Profit Margin (Quarterly) : 76.75% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 76.75% |
| March 31, 2026 | 76.87% |
| December 31, 2025 | 74.43% |
| September 30, 2025 | 74.90% |
| June 30, 2025 | 73.98% |
| March 31, 2025 | 74.31% |
| December 31, 2024 | 73.91% |
| September 30, 2024 | 74.22% |
| June 30, 2024 | 74.04% |
| March 31, 2024 | 73.98% |
| December 31, 2023 | 74.22% |
| September 30, 2023 | 74.40% |
| June 30, 2023 | 76.38% |
| March 31, 2023 | 74.45% |
| December 31, 2022 | 73.97% |
| September 30, 2022 | 74.13% |
| June 30, 2022 | 75.14% |
| March 31, 2022 | 74.55% |
| December 31, 2021 | 75.14% |
| September 30, 2021 | 74.12% |
| June 30, 2021 | 75.76% |
| March 31, 2021 | 75.14% |
| December 31, 2020 | 73.52% |
| September 30, 2020 | 73.66% |
| June 30, 2020 | 67.74% |
| Date | Value |
|---|---|
| March 31, 2020 | 73.06% |
| December 31, 2019 | 73.02% |
| September 30, 2019 | 73.83% |
| June 30, 2019 | 74.51% |
| March 31, 2019 | 73.88% |
| December 31, 2018 | 72.96% |
| September 30, 2018 | 71.98% |
| June 30, 2018 | 73.51% |
| March 31, 2018 | 73.42% |
| December 31, 2017 | 70.95% |
| September 30, 2017 | 73.35% |
| June 30, 2017 | 71.97% |
| March 31, 2017 | 72.71% |
| December 31, 2016 | 70.21% |
| September 30, 2016 | 71.65% |
| June 30, 2016 | 72.64% |
| March 31, 2016 | 72.10% |
| December 31, 2015 | 71.23% |
| September 30, 2015 | 71.53% |
| June 30, 2015 | 70.95% |
| March 31, 2015 | 72.73% |
| December 31, 2014 | 69.42% |
| September 30, 2014 | 70.81% |
| June 30, 2014 | 70.83% |
| March 31, 2014 | 71.06% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 52.64% |
| Boston Scientific Corp. | 66.50% |
| AngioDynamics, Inc. | 50.87% |
| Alphatec Holdings, Inc. | 62.90% |
| Baxter International, Inc. | 33.55% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.16% |
| Return on Assets | 1.64% |
| Return on Invested Capital | 1.87% |
| Profit Margin (Quarterly) | 5.83% |
| Operating Margin (Quarterly) | 6.29% |
| Return on Net Operating Assets | 2.20% |